REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable, Mechanically Ventilated Adults

Clinical trial NCT07155265 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07155265
Sponsor: Yancheng First People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Critical Illness; Mechanical Ventilation; Shock

Start date: 2025-10-01
Primary completion: 2027-06-30
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.